Cargando…
A Prospective, Randomized, Comparative Study of Topical Minocycline Gel 4% with Topical Clindamycin Phosphate Gel 1% in Indian Patients with Acne Vulgaris
Acne vulgaris is characterized by inflammatory and non-inflammatory skin lesions with a high prevalence among adolescents in India. Not enough studies are reported on the use of topical antibiotics for the management of acne in the Indian population. The proposed study aims to compare the efficacy a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526007/ https://www.ncbi.nlm.nih.gov/pubmed/37760751 http://dx.doi.org/10.3390/antibiotics12091455 |
_version_ | 1785110919825588224 |
---|---|
author | Shah, Bela Mistry, Deval Gonsalves, Nelry Vasani, Presha Dhoot, Dhiraj Barkate, Hanmant |
author_facet | Shah, Bela Mistry, Deval Gonsalves, Nelry Vasani, Presha Dhoot, Dhiraj Barkate, Hanmant |
author_sort | Shah, Bela |
collection | PubMed |
description | Acne vulgaris is characterized by inflammatory and non-inflammatory skin lesions with a high prevalence among adolescents in India. Not enough studies are reported on the use of topical antibiotics for the management of acne in the Indian population. The proposed study aims to compare the efficacy and safety of topical minocycline gel 4% with topical clindamycin gel 1% in the Indian population. A randomized, open-label, double-arm study was planned at two centers in India. One hundred patients were enrolled and randomized equally to two treatment arms. The drugs were applied once daily, preferably at the same time each day. The number of inflammatory and non-inflammatory lesions, as well as the investigator’s global assessment (IGA), were obtained at the baseline and on weeks 3, 6, 9, and 12. The change in these parameters from baseline to week 12 was compared between the two treatment arms. A tolerability assessment was also performed on selected parameters. The age of patients ranged between 14 and 31 years, with female preponderance in each arm. On week 12, the percent change in inflammatory and non-inflammatory lesions in the minocycline 4% arm was significantly higher than in the clindamycin 1% arm (p < 0.0001). The IGA treatment success was significantly higher in the minocycline arm compared to the clindamycin arm on weeks 9 and 12, with p-values of 0.001 and 0.015, respectively. Tolerability assessment revealed significantly improved parameter performance in the minocycline arm compared to the clindamycin arm. On subgroup analysis, in adolescents, minocycline was found to be more efficacious than clindamycin. The comparative assessment resulted in a significantly improved performance of minocycline gel 4% compared to clindamycin gel 1% in the Indian population, thus making it a preferred choice for the treatment of moderate-to-severe acne in India. |
format | Online Article Text |
id | pubmed-10526007 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105260072023-09-28 A Prospective, Randomized, Comparative Study of Topical Minocycline Gel 4% with Topical Clindamycin Phosphate Gel 1% in Indian Patients with Acne Vulgaris Shah, Bela Mistry, Deval Gonsalves, Nelry Vasani, Presha Dhoot, Dhiraj Barkate, Hanmant Antibiotics (Basel) Article Acne vulgaris is characterized by inflammatory and non-inflammatory skin lesions with a high prevalence among adolescents in India. Not enough studies are reported on the use of topical antibiotics for the management of acne in the Indian population. The proposed study aims to compare the efficacy and safety of topical minocycline gel 4% with topical clindamycin gel 1% in the Indian population. A randomized, open-label, double-arm study was planned at two centers in India. One hundred patients were enrolled and randomized equally to two treatment arms. The drugs were applied once daily, preferably at the same time each day. The number of inflammatory and non-inflammatory lesions, as well as the investigator’s global assessment (IGA), were obtained at the baseline and on weeks 3, 6, 9, and 12. The change in these parameters from baseline to week 12 was compared between the two treatment arms. A tolerability assessment was also performed on selected parameters. The age of patients ranged between 14 and 31 years, with female preponderance in each arm. On week 12, the percent change in inflammatory and non-inflammatory lesions in the minocycline 4% arm was significantly higher than in the clindamycin 1% arm (p < 0.0001). The IGA treatment success was significantly higher in the minocycline arm compared to the clindamycin arm on weeks 9 and 12, with p-values of 0.001 and 0.015, respectively. Tolerability assessment revealed significantly improved parameter performance in the minocycline arm compared to the clindamycin arm. On subgroup analysis, in adolescents, minocycline was found to be more efficacious than clindamycin. The comparative assessment resulted in a significantly improved performance of minocycline gel 4% compared to clindamycin gel 1% in the Indian population, thus making it a preferred choice for the treatment of moderate-to-severe acne in India. MDPI 2023-09-19 /pmc/articles/PMC10526007/ /pubmed/37760751 http://dx.doi.org/10.3390/antibiotics12091455 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Shah, Bela Mistry, Deval Gonsalves, Nelry Vasani, Presha Dhoot, Dhiraj Barkate, Hanmant A Prospective, Randomized, Comparative Study of Topical Minocycline Gel 4% with Topical Clindamycin Phosphate Gel 1% in Indian Patients with Acne Vulgaris |
title | A Prospective, Randomized, Comparative Study of Topical Minocycline Gel 4% with Topical Clindamycin Phosphate Gel 1% in Indian Patients with Acne Vulgaris |
title_full | A Prospective, Randomized, Comparative Study of Topical Minocycline Gel 4% with Topical Clindamycin Phosphate Gel 1% in Indian Patients with Acne Vulgaris |
title_fullStr | A Prospective, Randomized, Comparative Study of Topical Minocycline Gel 4% with Topical Clindamycin Phosphate Gel 1% in Indian Patients with Acne Vulgaris |
title_full_unstemmed | A Prospective, Randomized, Comparative Study of Topical Minocycline Gel 4% with Topical Clindamycin Phosphate Gel 1% in Indian Patients with Acne Vulgaris |
title_short | A Prospective, Randomized, Comparative Study of Topical Minocycline Gel 4% with Topical Clindamycin Phosphate Gel 1% in Indian Patients with Acne Vulgaris |
title_sort | prospective, randomized, comparative study of topical minocycline gel 4% with topical clindamycin phosphate gel 1% in indian patients with acne vulgaris |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526007/ https://www.ncbi.nlm.nih.gov/pubmed/37760751 http://dx.doi.org/10.3390/antibiotics12091455 |
work_keys_str_mv | AT shahbela aprospectiverandomizedcomparativestudyoftopicalminocyclinegel4withtopicalclindamycinphosphategel1inindianpatientswithacnevulgaris AT mistrydeval aprospectiverandomizedcomparativestudyoftopicalminocyclinegel4withtopicalclindamycinphosphategel1inindianpatientswithacnevulgaris AT gonsalvesnelry aprospectiverandomizedcomparativestudyoftopicalminocyclinegel4withtopicalclindamycinphosphategel1inindianpatientswithacnevulgaris AT vasanipresha aprospectiverandomizedcomparativestudyoftopicalminocyclinegel4withtopicalclindamycinphosphategel1inindianpatientswithacnevulgaris AT dhootdhiraj aprospectiverandomizedcomparativestudyoftopicalminocyclinegel4withtopicalclindamycinphosphategel1inindianpatientswithacnevulgaris AT barkatehanmant aprospectiverandomizedcomparativestudyoftopicalminocyclinegel4withtopicalclindamycinphosphategel1inindianpatientswithacnevulgaris AT shahbela prospectiverandomizedcomparativestudyoftopicalminocyclinegel4withtopicalclindamycinphosphategel1inindianpatientswithacnevulgaris AT mistrydeval prospectiverandomizedcomparativestudyoftopicalminocyclinegel4withtopicalclindamycinphosphategel1inindianpatientswithacnevulgaris AT gonsalvesnelry prospectiverandomizedcomparativestudyoftopicalminocyclinegel4withtopicalclindamycinphosphategel1inindianpatientswithacnevulgaris AT vasanipresha prospectiverandomizedcomparativestudyoftopicalminocyclinegel4withtopicalclindamycinphosphategel1inindianpatientswithacnevulgaris AT dhootdhiraj prospectiverandomizedcomparativestudyoftopicalminocyclinegel4withtopicalclindamycinphosphategel1inindianpatientswithacnevulgaris AT barkatehanmant prospectiverandomizedcomparativestudyoftopicalminocyclinegel4withtopicalclindamycinphosphategel1inindianpatientswithacnevulgaris |